Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Immunitybio Inc IBRX

Healthcare Biotechnology
Immunitybio, Inc. is a vertically integrated, clinical-stage biotechnology company developing therapies and vaccines that bolster the natural immune system to defeat cancers and infectious diseases. Using its proprietary platforms that amplify both the innate and adaptive branches of the immune system, its advances therapies and vaccines to defeat urologic and other cancers, as well as... see more

Recent & Breaking News (NDAQ:IBRX)

IBRX 12-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages ImmunityBio (IBRX) Investors with Substantial Losses to Contact Firm's Attorneys Before Aug. 29th Deadline in Securities Fraud Class Action

Newsfile August 17, 2023

INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in ImmunityBio, Inc. with Losses of $100,000 to Contact the Firm

Newsfile August 17, 2023

IBRX LAWSUIT ALERT: Levi & Korsinsky Notifies ImmunityBio, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

PR Newswire August 17, 2023

IBRX NOTICE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important August 29 Deadline in Securities Class Action - IBRX

Newsfile August 16, 2023

IBRX LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving ImmunityBio, Inc.

Accesswire August 16, 2023

INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in ImmunityBio, Inc. with Losses of $100,000 to Contact the Firm

Newsfile August 16, 2023

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of ImmunityBio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 29, 2023 - (NASDAQ: IBRX)

PR Newswire August 16, 2023

IBRX 2-WEEK DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages ImmunityBio (IBRX) Investors with Substantial Losses to Contact Firm's Attorneys Before Aug. 29th Deadline in Securities Fraud Class Action

Newsfile August 15, 2023

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in ImmunityBio, Inc. with Losses of $100,000 to Contact the Firm

Newsfile August 15, 2023

IBRX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of August 29, 2023 in the Class Action Filed on Behalf of ImmunityBio, Inc. Shareholders

PR Newswire August 15, 2023

ROSEN, A LEADING LAW FIRM, Encourages ImmunityBio, Inc. Investors with Losses to Secure Counsel Before Important August 29 Deadline in Securities Class Action - IBRX

PR Newswire August 14, 2023

IBRX Investors Have Opportunity to Lead ImmunityBio, Inc. Securities Fraud Lawsuit

PR Newswire August 14, 2023

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in ImmunityBio, Inc. with Losses of $100,000 to Contact the Firm

Newsfile August 14, 2023

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ImmunityBio, Inc. of Class Action Lawsuit and Upcoming Deadline - IBRX

Newsfile August 14, 2023

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating ImmunityBio, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors

PR Newswire August 14, 2023

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind ImmunityBio Investors of a Lead Plaintiff Deadline of August 29, 2023

PR Newswire August 14, 2023

TOP RANKED ROSEN LAW FIRM Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IBRX

Newsfile August 13, 2023

ROSEN, LEADING TRIAL ATTORNEYS, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IBRX

TheNewsWire August 12, 2023

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in ImmunityBio, Inc. with Losses of $100,000 to Contact the Firm

Newsfile August 11, 2023

IBRX NOTICE: ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IBRX

Newsfile August 11, 2023